These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1711626)

  • 21. Risk factors and the effects of xamoterol in idiopathic dilated cardiomyopathy.
    Watanabe K; Hirokawa Y; Suzuki K; Masani F; Otsuka H; Izumi T; Shibata A
    J Cardiol; 1992; 22(2-3):417-25. PubMed ID: 1339800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pimobendan on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.
    Hasenfuss G; Holubarsch C; Heiss HW; Allgeier M; Just H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S31-5. PubMed ID: 2478789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
    Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H
    Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.
    Eichhorn EJ; Bedotto JB; Malloy CR; Hatfield BA; Deitchman D; Brown M; Willard JE; Grayburn PA
    Circulation; 1990 Aug; 82(2):473-83. PubMed ID: 1973638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single and combined myocardial pharmacodynamics of xamoterol, isoprenaline and g-strophanthin in the isolated rabbit heart.
    Vigholt Sørensen E; Nielsen-Kudsk F
    Eur J Pharmacol; 1986 Jun; 125(3):363-71. PubMed ID: 2874040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of xamoterol, a beta 1-adrenoceptor partial agonist, on myocardial pH decreased by coronary occlusion in dogs.
    Sashida H; Sakai K; Hino T; Abiko Y
    Pharmacology; 1986; 33(6):301-10. PubMed ID: 2882527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of a partial agonist of beta 1 adrenergic receptors (ICI 118,587) on left ventricular performance and metabolism in coronary disease].
    Rousseau MF; Pouleur H; Etienne J; Mengeot P; Cheron P
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):76-84. PubMed ID: 6142702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
    Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K
    Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamics and myocardial oxygen metabolism of pulsus alternans in patients with dilative cardiomyopathy.
    Hasenfuss G; Holubarsch C; Heiss HW; Bonzel T; Funfack M; Revenaugh M; Meinertz T; Just H
    Clin Cardiol; 1987 May; 10(5):323-7. PubMed ID: 2954730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy.
    Beanlands RS; Bach DS; Raylman R; Armstrong WF; Wilson V; Montieth M; Moore CK; Bates E; Schwaiger M
    J Am Coll Cardiol; 1993 Nov; 22(5):1389-98. PubMed ID: 8227796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
    Boström PA; Johansson BW; Lecerof H; Lilja B; Torp A
    J Intern Med; 1989 Nov; 226(5):331-5. PubMed ID: 2572666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587.
    Pouleur H; Rousseau MF; Mengeot P; Veriter C; Vincent MF; Brasseur LA
    Eur Heart J; 1982 Dec; 3 Suppl D():123-7. PubMed ID: 6130945
    [No Abstract]   [Full Text] [Related]  

  • 35. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B; Sebening H; Busch U; Lutilsky L
    Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intravenous pimobendan (UDCG 115 BS) on hemodynamics and left ventricular volumes in idiopathic dilative cardiomyopathy.
    Permanetter B; Sebening H; Hartmann F; Baumann G; Lutilsky L
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):803-9. PubMed ID: 2481765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction.
    Sato H; Inoue M; Matsuyama T; Ozaki H; Shimazu T; Takeda H; Ishida Y; Kamada T
    Circulation; 1987 Jan; 75(1):213-20. PubMed ID: 2878742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy.
    Holubarsch C; Hasenfuss G; Heiss WH; Just H
    Am J Cardiol; 1988 Sep; 62(8):104E-107E. PubMed ID: 2970783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
    Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK
    Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.